Related Experiment Video
Updated: Mar 25, 2026
09:30
The Synthesis of RGD-functionalized Hydrogels as a Tool for Therapeutic Applications
Published on: October 7, 2016
12.0K
IGF-1 C Domain-Modified Hydrogel Enhances Cell Therapy for AKI
Guowei Feng1, Jimin Zhang2, Yang Li3
1School of Medicine and State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Bioactive Materials, Ministry of Education, College of Life Sciences, Nankai University, Tianjin, China; Department of Urology, Second Hospital of Tianjin Medical University, Tianjin Institute of Urology, Tianjin, China; and.
Journal of the American Society of Nephrology : JASN
|February 13, 2016
Summary
This study developed a bioactive hydrogel using insulin-like growth factor-1 (IGF-1) to improve stem cell therapy for acute kidney injury (AKI). The engineered hydrogel enhanced adipose-derived mesenchymal stem cell (ADSC) survival and promoted kidney repair in AKI models.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Nephrology
Background:
- Stem cell therapy for acute kidney injury (AKI) faces challenges with low cell retention and engraftment.
- Engineered microenvironments, including hydrogels, can mimic stem cell niches to improve therapeutic outcomes.
- Insulin-like growth factor-1 (IGF-1) plays a role in cell survival and tissue repair.
Purpose of the Study:
- To synthesize a bioactive hydrogel by immobilizing the C domain peptide of IGF-1 (IGF-1C) on chitosan.
- To investigate if the chitosan-IGF-1C hydrogel enhances adipose-derived mesenchymal stem cell (ADSC) survival and function in an AKI model.
- To evaluate the therapeutic potential of this engineered hydrogel for AKI treatment.
Main Methods:
- Synthesis of a chitosan-IGF-1C bioactive hydrogel.
- In vitro assessment of ADSC viability and paracrine effects within the hydrogel.
- In vivo transplantation of ADSCs with the hydrogel into an ischemic AKI model.
- Evaluation of renal function, cell survival, angiogenesis, and fibrosis using bioluminescence imaging and histological analysis.
Main Results:
- The chitosan-IGF-1C hydrogel significantly increased ADSC viability in vitro compared to controls.
- In vivo studies showed ameliorated renal function in AKI models treated with chitosan-IGF-1C hydrogel and ADSCs.
- Enhanced stem cell survival, increased angiogenesis, and reduced renal fibrosis were observed in the treated kidneys.
Conclusions:
- Immobilizing IGF-1C on a chitosan hydrogel creates a supportive microenvironment for ADSCs.
- This engineered hydrogel promotes stem cell survival and therapeutic efficacy in AKI.
- The chitosan-IGF-1C hydrogel represents a promising strategy for stem cell-based AKI therapy.
Related Concept Videos
01:22Acute Kidney Injury I: Introduction
1.2K
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.2K
01:29Acute Kidney Injury II: Pathophysiology
1.8K
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.8K
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
469
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
469
01:22Acute Kidney Injury VI: Nursing Management
663
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
663
01:20Acute Kidney Injury V: Interprofessional Care
455
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
455